This consensus gives clinicians practical guidance to reduce risk, support individualized and collaborative care, and stresses the importance of continuing insulin therapy in patients with type 1 diabetes, despite euglycemia and normal A1C values
doi: 10.1007/s12020-019-02055-z [DOI] [PubMed] [Google Scholar] 35
This article provides an overview of BPC 157, including its origins, potential uses, areas of ongoing research, possible side effects, general dosing considerations, and how it compares to other peptides
The goal after a BPC-157 cycle is to maintain healing momentum , support your newly restored tissue, and plan long-term strategies to prevent re-injury
Mol Genet Metab 116:107112 Longo N, Amat di San Filippo C, Pasquali M (2006) Disorders of carnitine transport and the carnitine cycle
From left to right: Ryan Pace, Meghan Azad, and Bridget McGann